ID   SW1398
AC   CVCL_3885
SY   SW-1398; SW 1398
DR   BTO; BTO:0003746
DR   MetaboLights; MTBLS227
DR   PRIDE; PXD001550
DR   Wikidata; Q54971080
RX   PubMed=25841592;
RX   PubMed=26537799;
CC   From: Scott and White Clinic; Temple; USA.
CC   Omics: Deep phosphoproteome analysis.
CC   Omics: N-glycan profiling.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 12
//
RX   PubMed=25841592; DOI=10.1016/j.jprot.2015.03.019;
RA   Piersma S.R., Knol J.C., de Reus I., Labots M., Sampadi B.K.,
RA   Pham T.V., Ishihama Y., Verheul H.M.W., Jimenez C.R.;
RT   "Feasibility of label-free phosphoproteomics and application to
RT   base-line signaling of colorectal cancer cell lines.";
RL   J. Proteomics 127:247-258(2015).
//
RX   PubMed=26537799; DOI=10.1074/mcp.M115.051235;
RA   Holst S., Deuss A.J.M., van Pelt G.W., van Vliet S.J.,
RA   Garcia-Vallejo J.J., Koeleman C.A.M., Deelder A.M., Mesker W.E.,
RA   Tollenaar R.A., Rombouts Y., Wuhrer M.;
RT   "N-glycosylation profiling of colorectal cancer cell lines reveals
RT   association of fucosylation with differentiation and caudal type
RT   homebox 1 (CDX1)/villin mRNA expression.";
RL   Mol. Cell. Proteomics 15:124-140(2016).
//